[144] CNO Financial Group, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for CNO Financial Group (CNO) reports a proposed sale of 6,420 common shares with an aggregate market value of $243,702.56. The shares are to be sold on the NYSE through Morgan Stanley Smith Barney LLC with an approximate sale date of 08/13/2025. Total shares outstanding reported are 96,931,934, giving readers the raw figures needed to assess scale.

The filing shows how the securities were acquired: 2,000 shares were restricted stock granted on 08/09/2024 and 4,420 were from a stock option exercise on 08/13/2025 paid in cash. The filer reports no sales in the past three months.

Insights

Securities Analyst

TL;DR The proposed sale is small relative to outstanding shares and appears routine under Rule 144.

The filing documents a planned disposition of 6,420 CNO common shares valued at $243,702.56. Given the reported 96,931,934 shares outstanding, this quantity is immaterial to overall equity supply and is unlikely to affect market pricing materially. The mix of restricted stock and option exercise as acquisition sources is consistent with typical insider liquidity events. Use of a national broker suggests standard execution channels.

Corporate Governance Expert

TL;DR Filing indicates compliance with disclosure rules and no recent insider sales, implying routine governance transparency.

The notice follows Rule 144 disclosure requirements by specifying the broker, share count, and acquisition history. The filer states Nothing to Report for securities sold in the prior three months, and documents both restricted grants and option exercise as acquisition sources. These elements reflect adherence to trading-plan and reporting protocols rather than signaling governance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6420	243702.56	96931934	08/13/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/09/2024	Restricted Stock	ISSUER			2000	08/09/2024	Not Applicable
Common	08/13/2025	Stock Option Exercise	ISSUER			4420	08/13/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CNO Form 144 disclose about the planned sale?

The filing discloses a proposed sale of 6,420 CNO common shares with aggregate market value of $243,702.56 on the NYSE.

Which broker will handle the CNO share sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, New York, NY.

When is the approximate date of sale listed in the CNO Form 144?

The filing lists an approximate date of sale of 08/13/2025.

How were the securities being sold acquired according to the filing?

Acquisition details show 2,000 shares as restricted stock acquired on 08/09/2024 and 4,420 shares from a stock option exercise on 08/13/2025 paid in cash.

Has the filer sold any CNO securities in the past three months?

The filing reports Nothing to Report for securities sold during the past three months.